Search Results - "Hilleman, DE"

Refine Results
  1. 1

    Pharmacoeconomic evaluation of COPD by Hilleman, D E, Dewan, N, Malesker, M, Friedman, M

    Published in Chest (01-11-2000)
    “…The clinical outcomes and health-care costs of a cohort of 413 patients with COPD are reported. This study was a retrospective pharmacoeconomic analysis…”
    Get more information
    Journal Article
  2. 2

    Nebulized opioids use in COPD by Foral, Pamela A, Malesker, Mark A, Huerta, Guillermo, Hilleman, Daniel E

    Published in Chest (01-02-2004)
    “…To evaluate the role of nebulized opioids in COPD. A MEDLINE search was completed to obtain pertinent clinical literature. Key search terms included the…”
    Get more information
    Journal Article
  3. 3

    Aggrenox: a fixed-dose combination of aspirin and dipyridamole by Lenz, TL, Hilleman, DE

    Published in The Annals of pharmacotherapy (01-11-2000)
    “…OBJECTIVE: To describe the pharmacology, pharmacokinetics, efficacy, and safety of a fixed-dose combination of aspirin and extended-release (ER) dipyridamole…”
    Get full text
    Journal Article
  4. 4

    Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients by Van den Berghe, Greet, Wouters, Pieter J, Kesteloot, Katrien, Hilleman, Daniel E

    Published in Critical care medicine (01-03-2006)
    “…OBJECTIVE:To perform an analysis of healthcare resource utilization with intensive insulin therapy, which has recently been shown to reduce morbidity and…”
    Get full text
    Journal Article
  5. 5

    Time to treatment and cost of thrombolysis : A multicenter comparison of tPA and rPA by SEYEDROUDBARI, A, KESSLER, E. R, MOOSS, A. N, WURDEMAN, R. L, BALA, M, HILLEMAN, D. E

    Published in Journal of thrombosis and thrombolysis (01-04-2000)
    “…This study reports a comparison of the time to treatment and cost of administration of alteplase (tPA) and reteplase (rPA) in patients with acute myocardial…”
    Get full text
    Journal Article
  6. 6

    Fixed-dose combination vs monotherapy in hypertension : a meta-analysis evaluation by HILLEMAN, D. E, RYSCHON, K. L, MOHIUDDIN, S. M, WURDEMAN, R. L

    Published in Journal of human hypertension (01-07-1999)
    “…Fixed-dose combination antihypertensive therapy has received interest since the publication of the JNC-VI report. Relatively few head-to-head comparative…”
    Get full text
    Journal Article
  7. 7

    Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography by Oldemeyer, J.Bradley, Biddle, W.Paul, Wurdeman, Richard L, Mooss, Aryan N, Cichowski, Erica, Hilleman, Daniel E

    Published in The American heart journal (01-12-2003)
    “…Contrast-induced nephropathy (CIN) after coronary angiography is associated with increased morbidity and mortality rates. Preliminary studies with…”
    Get full text
    Journal Article
  8. 8

    Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension by HILLEMAN, D. E, REYES, A. P, WURDEMAN, R. L, FAULKNER, M

    Published in Journal of human hypertension (01-08-2001)
    “…Recent hypertension trials have demonstrated the importance of achieving goal blood pressures to reduce the risk of target organ damage. In patients with…”
    Get full text
    Journal Article
  9. 9

    Conversion of Recent-Onset Atrial Fibrillation with Intravenous Amiodarone: A Meta-Analysis of Randomized Controlled Trials by Hilleman, Daniel E., Spinler, Sarah A.

    Published in Pharmacotherapy (01-01-2002)
    “…Study Objective. To evaluate efficacy and safety of intravenous amiodarone for conversion of recent‐onset atrial fibrillation. Data Sources. MEDLINE search of…”
    Get full text
    Journal Article
  10. 10

    Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD by Friedman, M, Serby, C W, Menjoge, S S, Wilson, J D, Hilleman, D E, Witek, Jr, T J

    Published in Chest (01-03-1999)
    “…To conduct a post hoc pharmacoeconomic evaluation of two double-blind, randomized, prospective, parallel group studies comparing the long-term efficacy and…”
    Get more information
    Journal Article
  11. 11

    Impact of Pharmacy Counseling on Compliance and Effectiveness of Combination Lipid-Lowering Therapy in Patients Undergoing Coronary Artery Revascularization: A Randomized, Controlled Trial by Faulkner, Michele A., Wadibia, E. Chuma, Lucas, B. Daniel, Hilleman, Daniel E.

    Published in Pharmacotherapy (01-04-2000)
    “…This randomized, controlled trial evaluated the impact of personalized follow‐up on compliance rates in high‐risk patients receiving combination lipid‐lowering…”
    Get full text
    Journal Article
  12. 12

    Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery by Hilleman, Daniel E, Mohiuddin, Syed M, Packard, Kathleen A

    Published in Chest (01-02-2004)
    “…Patients who continue to smoke following coronary artery bypass graft surgery (CABG) have substantially poorer outcomes than patients able to stop smoking…”
    Get more information
    Journal Article
  13. 13

    Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options by Friedman, M, Hilleman, D E

    Published in PharmacoEconomics (2001)
    “…The incidence, morbidity and mortality of chronic obstructive pulmonary disease (COPD) is rising throughout the world. The total economic cost of COPD in the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Angiotensin-Converting Enzyme Inhibitors and Stroke Risk: Benefit Beyond Blood Pressure Reduction? by Hilleman, Daniel E., Lucas Jr, B. Daniel

    Published in Pharmacotherapy (01-08-2004)
    “…Hypertension, a leading cause of morbidity and mortality, accounts for 25–49% of all strokes. Randomized placebo‐controlled trials primarily with diuretics and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery by Mooss, Aryan N., Wurdeman, Richard L., Mohiuddin, Syed M., Reyes, Antonio P., Sugimoto, Jeffrey T., Scott, Walter, Hilleman, Daniel E., Seyedroudbari, Ali

    Published in The American heart journal (01-07-2000)
    “…Background Supraventricular tachyarrhythmias are common after open heart surgery. Possible causative factors for these arrhythmias include operative trauma,…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Reteplase for Dysfunctional Hemodialysis Catheter Clearance by Hilleman, Daniel E., Dunlay, Robert W., Packard, Kathleen A.

    Published in Pharmacotherapy (01-02-2003)
    “…Study Objective. To evaluate the efficacy of reteplase administration in clearing hemodialysis catheters. Design. Open‐label, uncontrolled, observational…”
    Get full text
    Journal Article
  19. 19

    Antiplatelet Drug Resistance: Not Ready for Prime Time by Burns, Tammy L., Mooss, Aryan N., Hilleman, Daniel E.

    Published in Pharmacotherapy (01-11-2005)
    “…Antiplatelet drug therapy reduces vascular events in a wide range of patients. Although antiplatelet drug resistance is becoming well documented, a universal…”
    Get full text
    Journal Article
  20. 20

    Pharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Past, Present, and Future by Faulkner, Michele A., Hilleman, Daniel E.

    Published in Pharmacotherapy (01-10-2003)
    “…Pharmacologic treatment of chronic obstructive pulmonary disease (COPD) has evolved considerably during the past several decades. Initial treatment of the…”
    Get full text
    Journal Article